CN Patent

CN106317188A — 一种制备卡非佐米无定型物的方法

Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2017-01-11 · 9y expired

What this patent protects

本发明涉及一种治疗多发性骨髓瘤的新型肽类化合物卡非佐米的无定型物的制备方法，该方法包括以下步骤：1)将卡非佐米溶于有机溶剂；2)加入到非水抗溶剂中，析出无定型固体；3）分离出无定型固体。该方法原料损失极少，无需加水和浓缩，便于GMP条件下大规模生产，方法简便，可操作性强。

USPTO Abstract

本发明涉及一种治疗多发性骨髓瘤的新型肽类化合物卡非佐米的无定型物的制备方法，该方法包括以下步骤：1)将卡非佐米溶于有机溶剂；2)加入到非水抗溶剂中，析出无定型固体；3）分离出无定型固体。该方法原料损失极少，无需加水和浓缩，便于GMP条件下大规模生产，方法简便，可操作性强。

Drugs covered by this patent

Patent Metadata

Patent number
CN106317188A
Jurisdiction
CN
Classification
—
Expires
2017-01-11
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.